Highland Capital Calls For Sale of PDL BioPharma (PDLI)
Tweet Send to a Friend
Highland Capital Management, which hold approximately 4.7% of the common shares outstanding of PDL BioPharma, Inc. (NASDAQ: PDLI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
